Sinotherapeutics Inc. (SHA:688247)
China
· Delayed Price · Currency is CNY 9.69
-0.05 (-0.51%)
Mar 9, 2026, 4:00 PM EDT
Sinotherapeutics Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 4,436 | 4,355 | 4,517 | 4,978 | 7,593 | - | Upgrade
|
| Market Cap Growth | -5.54% | -3.58% | -9.25% | -34.45% | - | - | Upgrade
|
| Enterprise Value | 3,671 | 3,590 | 3,769 | 4,194 | 6,771 | - | Upgrade
|
| Last Close Price | 9.88 | 9.70 | 10.00 | 10.83 | 16.44 | - | Upgrade
|
| PE Ratio | 89.82 | 88.98 | 35.37 | 81.50 | 81.71 | - | Upgrade
|
| PS Ratio | 9.94 | 9.75 | 8.83 | 16.60 | 30.67 | - | Upgrade
|
| PB Ratio | 3.39 | 3.33 | 3.55 | 4.11 | 6.45 | - | Upgrade
|
| P/TBV Ratio | 3.48 | 3.42 | 3.66 | 4.28 | 6.74 | - | Upgrade
|
| P/FCF Ratio | - | - | 127.97 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 34.69 | 384.14 | 103.76 | - | Upgrade
|
| EV/Sales Ratio | 8.22 | 8.04 | 7.37 | 13.99 | 27.35 | - | Upgrade
|
| EV/EBITDA Ratio | 50.28 | 49.18 | 27.36 | 62.24 | 80.84 | - | Upgrade
|
| EV/EBIT Ratio | 67.11 | 65.63 | 31.55 | 94.67 | 116.33 | - | Upgrade
|
| EV/FCF Ratio | - | - | 106.79 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0 | 0 | 0.00 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.04 | Upgrade
|
| Debt / FCF Ratio | - | - | 0 | - | - | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.58 | -0.58 | -0.58 | -0.62 | -0.68 | -0.72 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.49 | -10.49 | -5.32 | -11.11 | -9.62 | -4.18 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -20.78 | 28.81 | 7.81 | -3.91 | Upgrade
|
| Asset Turnover | - | - | 0.36 | 0.22 | 0.23 | 0.39 | Upgrade
|
| Inventory Turnover | - | - | 2.63 | 2.34 | 1.96 | 1.71 | Upgrade
|
| Quick Ratio | - | - | 8.19 | 9.13 | 9.76 | 6.21 | Upgrade
|
| Current Ratio | - | - | 9.46 | 10.49 | 10.59 | 6.91 | Upgrade
|
| Return on Equity (ROE) | 3.79% | 3.79% | 10.29% | 5.12% | 9.87% | 21.29% | Upgrade
|
| Return on Assets (ROA) | - | - | 5.31% | 2.06% | 3.31% | 7.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.07% | 9.10% | 21.46% | 9.84% | 19.49% | 52.09% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 8.80% | 3.50% | 4.70% | 12.30% | Upgrade
|
| Earnings Yield | 1.10% | 1.12% | 2.83% | 1.23% | 1.22% | - | Upgrade
|
| FCF Yield | - | - | 0.78% | -0.52% | -1.36% | - | Upgrade
|
| Dividend Yield | 0.52% | - | 0.62% | 0.38% | 0.38% | - | Upgrade
|
| Payout Ratio | - | - | 21.83% | 46.02% | - | - | Upgrade
|
| Buyback Yield / Dilution | 2.44% | 2.44% | 2.92% | -11.22% | -3.32% | -0.21% | Upgrade
|
| Total Shareholder Return | 2.95% | 2.44% | 3.54% | -10.84% | -2.94% | -0.21% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.